, The Company’s strategies such as increasing more specialty cilinics, medical instruments and expanding into new market so as to drive a sustainable growth Cost of Hospital Operations The costs of
Public Company Limited (“the company”) held on 19 March, 2017 has approved the company to change the core business to property development. Thus, the Extraordinary General Meeting of Shareholders, held on
ขายทีล่ดลงเนื่องจากอยู่ระหว่างปลายโมเดล และก าลงัจะม ีMinor Change 2. อตัราก าไรขัน้ต้นรวม เท่ากบัร้อยละ 14.32 ลดลงจากงวดเดียวกนัของปีก่อนที่ ร้อยละ 17.14 เนื่องจากยอดขายที่ลดลง ในขณะที่มีค่าใช้จ่ายค่า
373.88 36.57 Other income 5.96 13.15 (7.19) (54.67) Cost of service 1,054.29 761.49 292.80 38.45 Expenses of sales 46.13 41.25 4.89 11.85 Expenses of management 170.92 133.48 37.44 28.05 Expenses of
net profit margin 2) higher depreciation resulted from additional investments in plant, machinery, and office renovations to improve production efficiency and reduce production cost, in order to prepare
the revenue from services and revenue from contract work. The total cost was reported at THB 695.4 million, decreased by THB 103.3 million or 12.9%. The gross profit for the year 2017 was decreased by
written by such board of directors. In case of any material amendment, change or modification to such policy and plan, intermediaries shall comply with the requirement set out in the first paragraph (1) or
6.01 Total Revenues 298.26 604.18 1,018.60 1,620.84 797.50 Costs 203.56 321.20 580.70 856.82 380.02 Selling And Administrative Expenses 82.93 57.10 126.84 433.21 329.69 Total Cost And Expenses 287.42
104.63 206.40 232.50 330.41 Total Cost And Expenses 311.97 308.01 612.69 648.10 873.08 EBITDA 70.47 199.96 277.07 64.54 -19.22 Depre. & Amor. 14.42 14.78 29.14 29.35 25.41 EBIT 56.05 185.18 247.93 35.19
471.03 668.85 401.84 Selling And Administrative Expenses 44.12 112.70 161.64 247.38 133.74 Total Cost And Expenses 122.03 386.45 572.98 870.76 78.51 EBITDA 10.40 -47.11 19.76 134.41 483.00 Depre. & Amor